Literature DB >> 8496748

Prevalence of medium-chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome.

R Arens1, D Gozal, K Jain, S Muscati, E T Heuser, J C Williams, T G Keens, S L Ward.   

Abstract

Disorders of fatty acid beta-oxidation have been suggested as playing a significant role in the sudden infant death syndrome (SIDS). To elucidate the role of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency in SIDS, we identified all cases of SIDS occurring in Los Angeles County between January 1986 through December 1991. A total of 1304 SIDS deaths were identified; tissue samples were collected in 1236 cases (94.8%). Extraction of DNA was successful in 1224 tissue samples (93.9%), which were examined for the presence of the G985 mutation, identified as occurring in more than 88% of affected cases of MCAD deficiency. Three heterozygotes and no homozygotes were identified; this incidence does not differ from that reported in the general population. Review of the pathologic specimens from the identified heterozygotes and from 18 ethnic-, age-, and sex-matched control subjects revealed significant fatty infiltration of all organs examined in one of the three heterozygotes and in none of the control subjects. We conclude that MCAD deficiency does not play a significant role in the causation of SIDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496748     DOI: 10.1016/s0022-3476(06)80010-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Gene variants predisposing to SIDS: current knowledge.

Authors:  Siri H Opdal; Torleiv O Rognum
Journal:  Forensic Sci Med Pathol       Date:  2010-07-11       Impact factor: 2.007

2.  Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis.

Authors:  C J Wilson; M P Champion; J E Collins; P T Clayton; J V Leonard
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

3.  Is the medium-chain acyl-CoA dehydrogenase G985 mutation involved in sudden infant death in Norway?

Authors:  S H Opdal; A Vege; O D Saugstad; T O Rognum
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

Review 4.  Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome.

Authors:  David S Paterson
Journal:  Respir Physiol Neurobiol       Date:  2013-07-10       Impact factor: 1.931

5.  Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.

Authors:  J B Lundemose; S Kølvraa; N Gregersen; E Christensen; M Gregersen
Journal:  Mol Pathol       Date:  1997-08

6.  Medium-chain acyl-CoA dehydrogenase deficiency does not correlate with apparent life-threatening events and the sudden infant death syndrome: results from phenylpropionate loading tests and DNA analysis.

Authors:  J M Penzien; G Molz; U N Wiesmann; J P Colombo; R Bühlmann; B Wermuth
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

Review 7.  Recommended clinical evaluation of infants with an apparent life-threatening event. Consensus document of the European Society for the Study and Prevention of Infant Death, 2003.

Authors:  André Kahn
Journal:  Eur J Pediatr       Date:  2003-12-03       Impact factor: 3.183

8.  Metabolic autopsy with next generation sequencing in sudden unexpected death in infancy: Postmortem diagnosis of fatty acid oxidation disorders.

Authors:  Takuma Yamamoto; Hiroyuki Mishima; Hajime Mizukami; Yuki Fukahori; Takahiro Umehara; Takehiko Murase; Masamune Kobayashi; Shinjiro Mori; Tomonori Nagai; Tatsushige Fukunaga; Seiji Yamaguchi; Koh-Ichiro Yoshiura; Kazuya Ikematsu
Journal:  Mol Genet Metab Rep       Date:  2015-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.